Skip to Content
Morningstar

Tandem Diabetes Care Inc TNDM

Morningstar Rating
Unlock
Stock XNAS Rating as of
$31.75 −1.21 (3.67%)
View Full Chart
As of Delayed Price Pre-Open: $31.50 0.00
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Price vs Fair Value

View History
TNDM is trading at a 1% discount.
Price
$31.75
Fair Value
$38.00
Uncertainty
Very High
1-Star Price
$24.00
5-Star Price
$79.00
Economic Moat
Vthj
Capital Allocation
Rsrpsyc

Bulls Say, Bears Say

Bulls

Tandem’s t:slim X2 features a low-profile, color touchscreen that is very user-friendly for patients new to insulin pumps.

Bears

Medtronic arguably enjoys more accurate and advanced algorithms thanks to its far larger patient user base and proprietary data—a major reason why it remains a step ahead of Tandem in closing the loop.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TNDM is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$32.96
Day Range
$31.31–33.07
52-Week Range
$13.82–41.92
Bid/Ask
$31.50 / $32.00
Market Cap
$2.05 Bil
Volume/Avg
6,472 / 1.9 Mil

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
2.76
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Tandem Diabetes Care Inc designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
2,400
Website
https://www.tandemdiabetes.com

Competitors

Valuation

View More
Metric
TNDM
PODD
DXCM
Price/Earnings (Normalized)
 —61.1390.46
Price/Book Value
 6.6415.8625.43
Price/Sales
 2.767.2116.04
Price/Cash Flow
 —36.4077.94
Price/Earnings
TNDM
PODD
DXCM

Financial Strength

Metric
TNDM
PODD
DXCM
Quick Ratio
 2.942.362.39
Current Ratio
 3.833.512.84
Interest Coverage
 −31.146.1429.34
Quick Ratio
TNDM
PODD
DXCM

Profitability

Metric
TNDM
PODD
DXCM
Return on Assets (Normalized)
 −10.52%8.02%10.03%
Return on Equity (Normalized)
 −29.38%33.45%28.40%
Return on Invested Capital (Normalized)
 −14.89%10.07%11.06%
Return on Assets
TNDM
PODD
DXCM
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Devices Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesLvgyhzpWqrzh$183.8 Bil
SYK
Stryker CorpSrpsplvzywDgm$127.8 Bil
MDT
Medtronic PLCDjyznstqWjhjmh$105.0 Bil
BSX
Boston Scientific CorpJrqtbgsqsMqfctlh$99.9 Bil
EW
Edwards Lifesciences CorpGyysnnmcmHzyhkbd$52.5 Bil
DXCM
DexCom IncDjxqbpmpcmXdxv$51.9 Bil
ZBH
Zimmer Biomet Holdings IncYwttcrkxyfQpv$24.9 Bil
ALGN
Align Technology IncJyrbbnxqQlkzp$22.6 Bil
PHG
Koninklijke Philips NV ADRPdmnxpgbGbtwhy$18.2 Bil
PODD
Insulet CorpGvtbgqvnttSttkw$11.6 Bil

Sponsor Center